Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

The Changing Face of Chronic Illness Management in Primary Care: A Qualitative Study of Underlying Influences and Unintended Outcomes

Linda M. Hunt, Meta Kreiner and Howard Brody
The Annals of Family Medicine September 2012, 10 (5) 452-460; DOI: https://doi.org/10.1370/afm.1380
Linda M. Hunt
1Department of Anthropology, Michigan State University, East Lansing, Michigan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: huntli@msu.edu
Meta Kreiner
1Department of Anthropology, Michigan State University, East Lansing, Michigan
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard Brody
2Institute for the Medical Humanities & Department of Family Medicine, University of Texas Medical Branch, Galveston, Texas
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Published eLetters

If you would like to comment on this article, click on Submit a Response to This article, below. We welcome your input.

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

  • Incentivizing Total Healthcare?
    Michael J. Oldani
    Published on: 17 December 2012
  • Re: Changing Face of Chronic Illness Management
    David C. Aron
    Published on: 09 October 2012
  • Re: Physician habits
    Robert M Hamm
    Published on: 30 September 2012
  • Re: Underlying Influences
    Robert M. Hamm
    Published on: 24 September 2012
  • Improving prescription practices through drug safety data
    Kalman Applbaum
    Published on: 14 September 2012
  • Well Done
    Michael S Kobernick
    Published on: 12 September 2012
  • Published on: (17 December 2012)
    Page navigation anchor for Incentivizing Total Healthcare?
    Incentivizing Total Healthcare?
    • Michael J. Oldani, Associate Professor, Medical Anthropology
    • Other Contributors:

    I found Hunt, Kreiner, and Brody's article extremely illuminating, timely, and critically important (as well as the comments/discussion to the piece). It seems their research and response point to a pharmaceutical nexus of sorts that is operating in and through the bodies of patients: pharma marketing, incentivization of medical care, and poly pharmacy. Outside of mental health treatments, there is probably no greater ar...

    Show More

    I found Hunt, Kreiner, and Brody's article extremely illuminating, timely, and critically important (as well as the comments/discussion to the piece). It seems their research and response point to a pharmaceutical nexus of sorts that is operating in and through the bodies of patients: pharma marketing, incentivization of medical care, and poly pharmacy. Outside of mental health treatments, there is probably no greater area of profit for Big Pharma than the triad of chronic illnesses: Diabetes (Type II), hypertension, and hyperlipidemia. What they clearly show is how easy it is for patients to end up broke, on polypharmaceutical cocktails, and actually feeling worse via side effects, drug interactions, and/or through the stress, anxiety or depression of their own pharmaceuticalization.

    I am going to repeat a few of the other comments to the article, but it's remarkable how the reliance on "numbers" by doctors, pharma, patients, and related medical industries (i.e., insurance companies, etc.) has completely altered modern healthcare. Medical systems continue to talk about the de/incentivization of doctors in order to structure appropriate care of patients, system compliance, and payment of services to doctors (and from third party payers). The British system (NHS) has mastered incentivization, so to speak, with good and bad outcomes (primary care can double their income if they are effective gatekeepers). Like any system gaming can occur, and patients are usually the losers - thrown out of practices to 'keep the numbers on track' - but it's usually rare. However, what I am most disturbed by is the fact that incentivization has infiltrated medicine to the point where it seems here to stay. So, for example, the issue of 'tight control' of type II diabetics, it's being revisited, which is great, but think about how things work now in the medical marketplace: We have doctors incentivized, meaning they can receive bonus pay for achieving 'tight control' in diabetic patients in their practice, while we have drug reps call on them, who are incentivized to convince these same doctors to write their products, and/or to enter patients into education programs and/or free medication programs. At the same time we have clinic/hospital administrative staff incentivized to keep doctors compliant on a variety of levels, while insurance company staff are incentivized to make sure they are not overpaying doctors, clinics, and hospitals. This milieu is the outcome of what anthropologists have described as "audit cultures" - albeit, the incentivized kind of auditing.

    On paper, auditing, assessing, etc. always makes good sense, however we see in the work by Hunt, Kreiner, and Brody that in the context of patient care it has negative health outcomes. Data, drugs, and money continue to circulate (usually profitably) for various systems and companies, but patients, often poor patients, carry the the burden(s) of incentivization. Doctors giving patients the 'hard sell': it's a matter of life and death, so you need to get serious about medical compliance, and then having to use pharma to offer 'free' meds (for one year max) seems like 'branding by proxy'. Doctors who increasingly are going to feel the squeeze of healthcare reform, again, especially for doctors who treat poorer patients, will be highly susceptible to incentives from all parties now involved in patient care.

    It's clear after reading this article that incentivization, chronic disease management and polypharmacy are now more than ever a matter of concern for critically-minded public health, bioethics and social science research.

    Competing interests:   None declared

    Show Less
    Competing Interests: None declared.
  • Published on: (9 October 2012)
    Page navigation anchor for Re: Changing Face of Chronic Illness Management
    Re: Changing Face of Chronic Illness Management
    • David C. Aron, Director of Health Services Research

    In this interesting paper is a reference to one of the interviewees: "As one family physician said: I was being a little bit lackadaisical with the A1c goal as 7.0[%] or less. I wouldn't really like to admit it, but the insurance companies making a financial carrot is probably one impetus for really cracking down on my diabetics to get them 7.0[%] or less. 7.1[%] don't cut it...anymore. It has to be 7.0[%] or less." This...

    Show More

    In this interesting paper is a reference to one of the interviewees: "As one family physician said: I was being a little bit lackadaisical with the A1c goal as 7.0[%] or less. I wouldn't really like to admit it, but the insurance companies making a financial carrot is probably one impetus for really cracking down on my diabetics to get them 7.0[%] or less. 7.1[%] don't cut it...anymore. It has to be 7.0[%] or less." This one statement sums up many of the issues raised in this paper and raises critical questions for the practice of medicine. First is the issue of the A1c goal. It is assumed that A1c<7% is the appropriate goal for everyone and it is true that the HEDIS measure for glycemic control was A1c<7% for all patients with diabetes aged 18-74--no exceptions. In fact, this measure was strongly promoted by an aligned industry (BigPharma), professional societies, some government agencies, and others.(1,2) Following the early termination of the ACCORD Trial (and publication of that trial as well as VADT and ADVANCE) prompted revision of that measure. This constituted an excellent example of a performance measure proceeding without the necessary scientific evidence.(2) Now, "individualizing targets" which seems all the rage.(3,4) Despite voices calling for this intuitively obvious step, it took years before the groups who had pushed tight glycemic control so hard relented. It should, but doesn't, go without saying, that pursuit of tight glycemic control should have potential for benefit of that individual patient. The long time course for development of complications means that life expectancy enters into the decision-making calculus. Another assumption is that pursuit of tight glycemic control is without harm, most notably hypoglycemia. However, the frequency of hypoglycemia, even severe hypoglycemia (requiring third party assistance) seems to have been ignored.(5) Practicing clinicians knew otherwise, but studies documenting the high frequency and potential harms, e.g., falls in the elderly, have been slower in coming. Pay-for-performance is a form of cybernetic management: "quantified targets are set for performance at some point in the future, the time path towards the target is forecast, and then actual outcomes are measured and compared with forecasts, with the variance fed back to determine what adjustments are required to bring performance back to target." (6, p39). However, unlike that classic cybernetic system of a heater and a thermostat, in this P4P world, undertreatment is incentivized, but overtreatment is not dis-incentivized. Finally, what does this all say about professionalism? Nothing good, I am afraid. Fortunately, the data on the effectiveness of P4P are mixed at best.(7) That should give us some hope that clinicians are willing to use their judgment. However, there are too many instances of gaming to feel smug. In the end, we as clinicians should be partners with our patients to help them negotiate the challenges of chronic illness where tradeoffs of all sorts are required. Chronic illness is far too complex to be left in the clutches of the simplistic number crunchers.

    David C. Aron, MD, MS The opinions expressed are my own and do not represent those of the VA or any other agency.

    1. Aron D, Pogach L. Transparency standards for diabetes performance measures. JAMA 2009;301:210-212.

    2. Pogach L, Aron DC. Sudden acceleration of diabetes quality measures. JAMA 2011 Feb 16;305(7):709-710.

    3. Ismail-Beigi F, Moghissi ES, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials. Annals Internal Medicine 2011;154(April 19):554-559.

    4. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of Hyperglycemia in Type2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. Published online before print April 19, 2012.

    5. Pogach L, Aron DC. The Other Side of Quality Improvement in Diabetes for Seniors: A Proposal for an Over-Treatment Glycemic Measure. Arch Int Med 2012; Less is More, online prior to print, Sept., 2012.

    6. Stacey R D. Complexity and Organizational Reality: Uncertainty and the Need to Rethink Management after the Collapse of Investment Capitalism, 2nd edition, London UK; Routledge, 2010.

    7. Van Herck P, De Smedt D, Annemans L, et al. Systematic review: Effects, design choices, and context of pay-for-performance in health care. BMC Health Services Research 2010;10:247

    Competing interests:   None declared

    Show Less
    Competing Interests: None declared.
  • Published on: (30 September 2012)
    Page navigation anchor for Re: Physician habits
    Re: Physician habits
    • Robert M Hamm, Professor

    The transcribed conversations reported by Hunt, Kreiner, & Brody (2012) give evidence that physicians in a variety of clinical settings are following very similar personal scripts. Scripts are habitual ways of thinking and interacting with patients around a medical problem (R. M. Hamm, 2003). Though perhaps no longer conscious, they are flexible, developed first during a physician's education but shaped during practic...

    Show More

    The transcribed conversations reported by Hunt, Kreiner, & Brody (2012) give evidence that physicians in a variety of clinical settings are following very similar personal scripts. Scripts are habitual ways of thinking and interacting with patients around a medical problem (R. M. Hamm, 2003). Though perhaps no longer conscious, they are flexible, developed first during a physician's education but shaped during practice by new literature, interactions with peers, and reflection (Abernathy & Hamm, 1995). As the paper suggests, the high frequency of conversations with drug reps is probably one reason that most physicians' scripts for treatment of patients at risk of cardiovascular disease focus almost exclusively on the use of medication to attain blood pressure and blood glucose targets.

    It is clear that these physicians' scripts leave out important considerations such as the patient as a person, adverse side effects, the cost of medications and the burden of managing multiple daily doses. It is also clear, from this and other studies (Fischer et al., 2009), that physicians don't accurately perceive how they are influenced: they say they view the marketers' information objectively, yet they prescribe the drugs they've been detailed on more often. This automated, unaware thinking is characteristic of physicians' use of scripts (R.M. Hamm, 2009). Script content depends on the strength of association between situations and the idea of doing an action, and that can be influenced by repeated exposure.

    Scripts may also be influenced by unconscious norms of politeness. Receiving a gift activates the desire to reciprocate. One did not promise to prescribe, but only to consider prescribing; nonetheless, one prescribes. In social settings people refrain from criticizing others. Accordingly a physician may decline to argue every point that the pharm rep lays out as the clinic staff file past filling their plates. While the most authoritative physician in the room may be mentally adding that "grain of salt" to what the rep says, others in line see only that their lead physician seems to agree, so they assume the claims are accurate and add the possibility of using the drug to their own scripts.

    If repeated messages so powerfully influence behavior, clinicians should make a point of verbalizing treatment strategies other than medication adjustment to reduce cardiovascular risk, and individual patient goals other than to those articulated in the generic guidelines. These statements should be repeated daily to oneself, to each other, and to patients. The physician's mind is important territory, for its contents determine how patients are cared for. It should be governed by physicians themselves, not colonized by whoever talks to them while buying their lunch. Perhaps physicians should buy each other lunch.

    Robert M. Hamm, PhD

    Department of Family and Preventive Medicine

    University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

    Abernathy, C. M., & Hamm, R. M. (1995). Surgical Intuition. Philadelphia, PA: Hanley and Belfus.

    Fischer, M. A., Keough, M. E., Baril, J. L., Saccoccio, L., Mazor, K. M., Ladd, E., . . . Gurwitz, J. H. (2009). Prescribers and pharmaceutical representatives: why are we still meeting? J Gen Intern Med, 24(7), 795- 801. doi: 10.1007/s11606-009-0989-6

    Hamm, R. M. (2003). Medical decision scripts: Combining cognitive scripts and judgment strategies to account fully for medical decision making. In D. Hardman & L. Macchi (Eds.), Thinking: Psychological Perspectives on Reasoning, Judgment and Decision Making (pp. 315-345). Chichester, West Sussex, GB: John Wiley & Sons, Ltd.

    Hamm, R. M. (2009). Automatic thinking. In M. W. Kattan (Ed.), Encyclopedia of Medical Decision Making (Vol. 1, pp. 45-49). Thousand Oaks, CA: Sage Publications.

    Hunt, L. M., Kreiner, M., & Brody, H. (2012). The changing face of chronic illness management in primary care: a qualitative study of underlying influences and unintended outcomes. Ann Fam Med, 10(5), 452- 460. doi: 10.1370/afm.1380

    Competing interests:   None declared

    Show Less
    Competing Interests: None declared.
  • Published on: (24 September 2012)
    Page navigation anchor for Re: Underlying Influences
    Re: Underlying Influences
    • Robert M. Hamm, Professor
    • Other Contributors:

    Hunt, Kreiner, and Brody noted that "the clinical consultations we observed focused heavily on choosing and adjusting medications, to the near exclusion of other considerations, such as diet and lifestyle" (p. 455). But there is such good evidence that counseling patients to change diet and exercise behavior is effective in reducing cardiovascular risk (Fisher et al., 2011; Hankinson et al., 2010; Lin, O'Connor, Whitlock...

    Show More

    Hunt, Kreiner, and Brody noted that "the clinical consultations we observed focused heavily on choosing and adjusting medications, to the near exclusion of other considerations, such as diet and lifestyle" (p. 455). But there is such good evidence that counseling patients to change diet and exercise behavior is effective in reducing cardiovascular risk (Fisher et al., 2011; Hankinson et al., 2010; Lin, O'Connor, Whitlock, & Beil, 2010; Ross et al., 2000). Extrapolating from the connection the paper makes between the frequent, friendly relations with pharm reps and the doctors' emphasis on using drugs to reduce the signs of cardiovascular risk, why aren't there diet industry reps and gym reps visiting doctors' offices? Buying lunch is not restricted to pharmaceutical and device manufacturers and the occasional academic detailer (Soumerai & Avorn, 1990). Given the focus of much of physicians' drug-rep sponsored activities (eating, recreation), young, slender, and fit representatives of the diet and exercise industries could naturally provide doctor and staff with healthy sample meals and gym visits, talking over carrots and curls about how patients' cardiovascular risk can be reduced through losing weight and lifting weights. Perhaps the problem is lack of monopoly; patients can go anywhere for help with lifestyle change, so a particular gym or diet program's investment in detailing would likely not pay off.

    Ingrid E. Young and Robert M. Hamm

    Fisher, E. B., Fitzgibbon, M. L., Glasgow, R. E., Haire-Joshu, D., Hayman, L. L., Kaplan, R. M., . . . Ockene, J. K. (2011). Behavior matters.. Am J Prev Med, 40(5), e15-30. Hankinson, A. L., Daviglus, M. L., Bouchard, C., Carnethon, M., Lewis, C. E., Schreiner, P. J., . . . Sidney, S. (2010). Maintaining a high physical activity level over 20 years and weight gain. JAMA, 304(23), 2603-2610. Lin, J. S., O'Connor, E., Whitlock, E. P., & Beil, T. L. (2010). Behavioral counseling to promote physical activity and a healthful diet to prevent cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, 153(11), 736-750. Ross, R., Dagnone, D., Jones, P. J., Smith, H., Paddags, A., Hudson, R., & Janssen, I. (2000). Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med, 133(2), 92-103. Soumerai, S. B., & Avorn, J. (1990). Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA, 263(4), 549-556.

    Competing interests:   None declared

    Show Less
    Competing Interests: None declared.
  • Published on: (14 September 2012)
    Page navigation anchor for Improving prescription practices through drug safety data
    Improving prescription practices through drug safety data
    • Kalman Applbaum, Professor, Medical Anthropology

    Hunt, Kreiner, & Brody's carefully researched and forthrightly written article may signal the state of affairs pertaining to a significant segment of the diabetes/metabolic syndrome patient population. The authors identify the potential harms of the recent expansion of and pressure to comply with early and intensive pharmacological algorithms for the management of type 2 diabetes.

    There is a considerable and...

    Show More

    Hunt, Kreiner, & Brody's carefully researched and forthrightly written article may signal the state of affairs pertaining to a significant segment of the diabetes/metabolic syndrome patient population. The authors identify the potential harms of the recent expansion of and pressure to comply with early and intensive pharmacological algorithms for the management of type 2 diabetes.

    There is a considerable and growing body of research supporting the assertion that iatrogenic prescribing habits, including inappropriate prescription, polypharmacy/over-treatment, and clinician inattentiveness to adverse drug response (which may engender further prescriptions rather than tapering or cessation of existing ones - the "cascading effect" identified by the authors), is common to many areas of medicine.

    The authors identify several possible causes of harmful prescription practices, most tracing at root to the vast, all-encompassing pharmaceutical marketing apparatus. In my experience, most MDs ignore or mistrust studies about the effects of pharmaceutical marketing for two reasons. First, unbeknownst to them most pharmaceutical marketing in fact takes place where they cannot see it - at the level of the manipulation of clinical science and in efforts to influence professional, public, and regulatory judgment regarding the utility, efficacy, and pricing of proposed new drugs. As for the influence of drug reps, as reported in this study MDs tend to reject the insinuation that reps might have an effect on their decision-making. Every study conducted independently and by the pharmaceutical industry with which I am familiar, however, controverts this self-serving belief.

    It may be unreasonable to expect to alter the marketing activities of big pharma. Their interests are too well-funded, and political and popular acceptance for their "free market" practices is too entrenched.

    We can, however, aim to mitigate the iatrogenic effects of misinformed prescription practices by expanding and improving the data on drug safety. Research shows that 50% of people taking a medicine suffer an adverse event or side effect due to treatment. Independent research and statistics indicate that over 95% of adverse events remain unreported. When MDs do report it is often in cursory fashion, not addressing the human (quality of life) costs that patients who have been harmed must bear. In some fields, such as psychiatry, it is extremely difficult to distinguish the effects of the drugs from those of the sickness.

    Our medical system is fixated upon efficacy of drug treatments to the detriment of bids to ascertain and classify side effects in sub- populations. Studies regarding the effects of dependency and withdrawal associated with long-term application of drugs are unpopular, even while the industry has shifted most of its energies to developing and promoting drugs designed for rest-of-lifetime use.

    Neither the authors of this excellent study nor I are cynical as to the conscientious intentions of most clinicians. If physicians had at their disposal improved side effect data, made available to them through trusted, independent sources, the dangers of improper prescriptions would certainly be mitigated.

    Kalman Applbaum Professor of Medical Anthropology University of Wisconsin, Milwaukee Founding Member, Data Based Medicine (https://www.rxisk.org/Default.aspx)

    Competing interests:   None declared

    Show Less
    Competing Interests: None declared.
  • Published on: (12 September 2012)
    Page navigation anchor for Well Done
    Well Done
    • Michael S Kobernick, Medical Director

    As a medical director developing a new national health plan with Ascension Health I am appreciative of information regarding the possible negative effects of pay-for-performance programs. It supports my position that we need to incentivize interventions that include education, counseling and judicious use of medications. Focusing physicians on a number rather than individual well-being may be dangerous to the individua...

    Show More

    As a medical director developing a new national health plan with Ascension Health I am appreciative of information regarding the possible negative effects of pay-for-performance programs. It supports my position that we need to incentivize interventions that include education, counseling and judicious use of medications. Focusing physicians on a number rather than individual well-being may be dangerous to the individuals we are trying to help. Thank you for this thought provoking piece.

    Michael Kobernick, MD, MS, FAAFP, FAAEM Executive Director Chief Medical Officer Ascension Health - SmartHealth

    Competing interests:   None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 10 (5)
The Annals of Family Medicine: 10 (5)
Vol. 10, Issue 5
September/October 2012
  • Table of Contents
  • Index by author
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Changing Face of Chronic Illness Management in Primary Care: A Qualitative Study of Underlying Influences and Unintended Outcomes
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Changing Face of Chronic Illness Management in Primary Care: A Qualitative Study of Underlying Influences and Unintended Outcomes
Linda M. Hunt, Meta Kreiner, Howard Brody
The Annals of Family Medicine Sep 2012, 10 (5) 452-460; DOI: 10.1370/afm.1380

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
The Changing Face of Chronic Illness Management in Primary Care: A Qualitative Study of Underlying Influences and Unintended Outcomes
Linda M. Hunt, Meta Kreiner, Howard Brody
The Annals of Family Medicine Sep 2012, 10 (5) 452-460; DOI: 10.1370/afm.1380
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • FACTORS AFFECTING DIAGNOSIS AND TREATMENT
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • How often do both core competencies of shared decision making occur in family medicine teaching clinics?
  • Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study
  • Challenges faced by primary care physicians when prescribing for patients with chronic diseases in a teaching hospital in Malaysia: a qualitative study
  • MAXimising Involvement in MUltiMorbidity (MAXIMUM) in primary care: protocol for an observation and interview study of patients, GPs and other care providers to identify ways of reducing patient safety failures
  • In This Issue: Local+Familiar=Healthier
  • Google Scholar

More in this TOC Section

  • Shared Decision Making Among Racially and/or Ethnically Diverse Populations in Primary Care: A Scoping Review of Barriers and Facilitators
  • Convenience or Continuity: When Are Patients Willing to Wait to See Their Own Doctor?
  • Feasibility and Acceptability of the “About Me” Care Card as a Tool for Engaging Older Adults in Conversations About Cognitive Impairment
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
  • Methods:
    • Qualitative methods
  • Other research types:
    • Professional practice
  • Other topics:
    • Communication / decision making
    • Multimorbidity
    • Patient perspectives

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine